Curated drug content for COVID-19 and other infectious diseases provide clinicians with clear and actionable evidence. Monographs are evidence-based, fully referenced documents that provide brief highlights (Quick Answers) and comprehensive information (In-Depth Answers) for drug dosing, drug interactions, adverse effects, pregnancy warnings, indications, cautions, therapeutic class, and brand information.
Drug monographs help support safe and effective drug therapy decisions from the world’s biomedical literature. Strength of evidence and efficacy ratings help guide clinical decision-making, whether evaluating a more common drug therapy option or options for a rare disease or condition.
Evidence-Based Reports are focused, fully referenced artices to provide clinicians with a concise resource on a variety of topics, including drug therapies, drug guidelines and the management of adverse drug reactions and infectious outbreaks. These reports are designed to guide the clinician to help reduce medication errors and improve patient outcomes.
Clinician focused, comprehensive information for COVID-19 and
other infectious diseases on how to evaluate and treat patients based on the most
current, relevant and valid clinical evidence and guidelines. Disease monographs provide the most useful information to healthcare professionals at the point of care to improve health outcomes worldwide.
Patient focused handouts that provide actionable, evidence-based medical information (CareNotes®) for medical condition management and drug information (DrugNotes®) written in consumer-friendly plain language. Information is tailored to the point of care, such as a doctor’s office, emergency department, or ambulatory facility.